EUVIMEDEUVIMED entdecken
Crossref

Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis

Ke Hu, Pin Jiang, Jiaxin Hu, Bing Song, Ya Hou, Jinxuan Zhao, Haiting Chen, Jun Xie

Journal of Bioenergetics and Biomembranes · 2024-08 · 56 (4) · 361-371

DOI: 10.1007/s10863-024-10020-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bioenergetics and Biomembranes, online erschienen am 14.05.2024. Verfasst von Ke Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Drum Tower Hospital of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. Hauptthemen laut MEDLINE: Ferroptosis, Benzhydryl Compounds, Glucosides, Lipopolysaccharides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Anhui Provincial Natural Science Research Project for Higher Education Institutions, Collaborative Project between the First Affiliated Hospital of Anhui Medical University and Hefei Zhongke Ion Medical Technology Equipment Co., Ltd., the Funds for Distinguished Young Scientists in Nanjing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Septic cardiomyopathy is a severe cardiovascular disease with a poor prognosis. Previous studies have reported the involvement of ferroptosis in the pathogenesis of septic cardiomyopathy. SGLT2 inhibitors such as dapagliflozin have been demonstrated to improve ischemia-reperfusion injury by alleviating ferroptosis in cardiomyocyte. However, the role of dapagliflozin in sepsis remains unclear. Therefore, our study aims to investigate the therapeutic effects of dapagliflozin on LPS-induced septic cardiomyopathy. Our results indicate that dapagliflozin improved cardiac function in septic cardiomyopathy experimental mice. Mechanistically, dapagliflozin works by inhibiting the translation of key proteins involved in ferroptosis, such as GPX4, FTH1, and SLC7A11. It also reduces the transcription of lipid peroxidation-related mRNAs, including PTGS2 and ACSL4, as well as iron metabolism genes TFRC and HMOX1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBenzhydryl CompoundsGlucosidesLipopolysaccharidesAnimalsMiceMaleCardiomyopathiesMice, Inbred C57BLPhospholipid Hydroperoxide Glutathione PeroxidaseAmino Acid Transport System y+Myocytes, Cardiac

Stichwörter der Autor:innen

CardiomyopathyDapagliflozinFerroptosisLipopolysaccharide

Substanzen

Benzhydryl CompoundsdapagliflozinGlucosidesLipopolysaccharidesglutathione peroxidase 4, mousePhospholipid Hydroperoxide Glutathione PeroxidaseSlc7a11 protein, mouseAmino Acid Transport System y+

Autor:innen und Institutionen

  • The Affiliated Drum Tower Hospital of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
  • Department of General Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
  • Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi, 445000, Hubei, China.
  • Department of Cardiology, National Cardiovascular Disease Regional Center for Anhui, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, MOE Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing, 210008, Jiangsu, Ch…
  • Department of Cardiology, National Cardiovascular Disease Regional Center for Anhui, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. cht141230004@163.com.

Förderung

  • Anhui Provincial Natural Science Research Project for Higher Education Institutions
  • Collaborative Project between the First Affiliated Hospital of Anhui Medical University and Hefei Zhongke Ion Medical Technology Equipment Co., Ltd.
  • the Funds for Distinguished Young Scientists in Nanjing
  • China Postdoctoral Science Foundation
  • Anhui Medical University Research Enhancement Program Funding Project
  • the National Natural Science Foundation of China
  • the Jiangsu Distinguished Young Scholars Fund
  • Nanjing Postdoctoral Science Foundation for Jinxuan Zhao and Jiangsu “Mass Innovation and Entrepreneurship” Talent Program to Jinxuan Zhao

Zitieren

APA

Hu, K., Jiang, P., Hu, J., Song, B., Hou, Y., Zhao, J., Chen, H., & Xie, J. (2024). Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis. Journal of Bioenergetics and Biomembranes, 56(4), 361-371. https://doi.org/10.1007/s10863-024-10020-3

Vancouver

Hu K, Jiang P, Hu J, Song B, Hou Y, Zhao J, et al. Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis. Journal of Bioenergetics and Biomembranes. 2024;56(4):361-371. doi:10.1007/s10863-024-10020-3

BibTeX
@article{Hu2024,
  author = {Hu, Ke and Jiang, Pin and Hu, Jiaxin and Song, Bing and Hou, Ya and Zhao, Jinxuan and Chen, Haiting and Xie, Jun},
  title = {Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis},
  journal = {Journal of Bioenergetics and Biomembranes},
  year = {2024},
  volume = {56},
  number = {4},
  pages = {361--371},
  doi = {10.1007/s10863-024-10020-3}
}
Kostenlos starten →